AN EVALUATION OF STRATEGIES IN PHASE IIB/III TRIALS FOR HIV-1 VACCINATION OF AT-RISK COMMUNITIES

dc.contributor.author	Silva, U. De
dc.contributor.author	Kotalawala, S.
dc.date.accessioned	2021-01-14T08:44:12Z
dc.date.available	2021-01-14T08:44:12Z
dc.date.issued	2018-06-15
dc.identifier.issn	2659-2193
dc.identifier.uri	http://220.247.247.85:8081/handle/123456789/36871
dc.description	Public Health-HIV, School of Science, BMS, Sri Lanka	en_US
dc.language.iso	en	en_US
dc.publisher	GARI Publisher	en_US
dc.relation.ispartofseries	Volume. 04;No. 03
dc.subject	HIV-1 vaccination	en_US
dc.subject	efficacy trials	en_US
dc.subject	vaccination strategies	en_US
dc.subject	immune correlates	en_US
dc.title	AN EVALUATION OF STRATEGIES IN PHASE IIB/III TRIALS FOR HIV-1 VACCINATION OF AT-RISK COMMUNITIES	en_US
dc.type	Article	en_US
dc.identifier.accno	45744	en_US